These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

391 related items for PubMed ID: 18174366

  • 1. VIP differentially activates beta2 integrins, CR1, and matrix metalloproteinase-9 in human monocytes through cAMP/PKA, EPAC, and PI-3K signaling pathways via VIP receptor type 1 and FPRL1.
    El Zein N, Badran B, Sariban E.
    J Leukoc Biol; 2008 Apr; 83(4):972-81. PubMed ID: 18174366
    [Abstract] [Full Text] [Related]

  • 2. The neuropeptide pituitary adenylate cyclase activating polypeptide modulates Ca2+ and pro-inflammatory functions in human monocytes through the G protein-coupled receptors VPAC-1 and formyl peptide receptor-like 1.
    El Zein N, Badran B, Sariban E.
    Cell Calcium; 2008 Mar; 43(3):270-84. PubMed ID: 17651798
    [Abstract] [Full Text] [Related]

  • 3. The neuropeptide pituitary adenylate cyclase activating protein is a physiological activator of human monocytes.
    El Zein N, Corazza F, Sariban E.
    Cell Signal; 2006 Feb; 18(2):162-73. PubMed ID: 15993038
    [Abstract] [Full Text] [Related]

  • 4. IGF-I and vasoactive intestinal peptide (VIP) regulate cAMP-response element-binding protein (CREB)-dependent transcription via the mitogen-activated protein kinase (MAPK) pathway in pituitary cells: requirement of Rap1.
    Fernández M, Sánchez-Franco F, Palacios N, Sánchez I, Cacicedo L.
    J Mol Endocrinol; 2005 Jun; 34(3):699-712. PubMed ID: 15956341
    [Abstract] [Full Text] [Related]

  • 5. Cyclic AMP induces integrin-mediated cell adhesion through Epac and Rap1 upon stimulation of the beta 2-adrenergic receptor.
    Rangarajan S, Enserink JM, Kuiperij HB, de Rooij J, Price LS, Schwede F, Bos JL.
    J Cell Biol; 2003 Feb 17; 160(4):487-93. PubMed ID: 12578910
    [Abstract] [Full Text] [Related]

  • 6. Vasoactive intestinal peptide upregulates MUC2 intestinal mucin via CREB/ATF1.
    Hokari R, Lee H, Crawley SC, Yang SC, Gum JR, Miura S, Kim YS.
    Am J Physiol Gastrointest Liver Physiol; 2005 Nov 17; 289(5):G949-59. PubMed ID: 16227528
    [Abstract] [Full Text] [Related]

  • 7. Formyl peptide receptor like 1 differentially requires mitogen-activated protein kinases for the induction of glial fibrillary acidic protein and interleukin-1alpha in human U87 astrocytoma cells.
    Kam AY, Tse TT, Kwan DH, Wong YH.
    Cell Signal; 2007 Oct 17; 19(10):2106-17. PubMed ID: 17643960
    [Abstract] [Full Text] [Related]

  • 8. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit the MEKK1/MEK4/JNK signaling pathway in endotoxin-activated microglia.
    Delgado M.
    Biochem Biophys Res Commun; 2002 May 03; 293(2):771-6. PubMed ID: 12054537
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The signalling profile of recombinant human orexin-2 receptor.
    Tang J, Chen J, Ramanjaneya M, Punn A, Conner AC, Randeva HS.
    Cell Signal; 2008 Sep 03; 20(9):1651-61. PubMed ID: 18599270
    [Abstract] [Full Text] [Related]

  • 11. Differential signaling of formyl peptide receptor-like 1 by Trp-Lys-Tyr-Met-Val-Met-CONH2 or lipoxin A4 in human neutrophils.
    Bae YS, Park JC, He R, Ye RD, Kwak JY, Suh PG, Ho Ryu S.
    Mol Pharmacol; 2003 Sep 03; 64(3):721-30. PubMed ID: 12920210
    [Abstract] [Full Text] [Related]

  • 12. Vasoactive intestinal peptide transactivates the androgen receptor through a protein kinase A-dependent extracellular signal-regulated kinase pathway in prostate cancer LNCaP cells.
    Xie Y, Wolff DW, Lin MF, Tu Y.
    Mol Pharmacol; 2007 Jul 03; 72(1):73-85. PubMed ID: 17430995
    [Abstract] [Full Text] [Related]

  • 13. Serum amyloid A stimulates matrix-metalloproteinase-9 upregulation via formyl peptide receptor like-1-mediated signaling in human monocytic cells.
    Lee HY, Kim MK, Park KS, Bae YH, Yun J, Park JI, Kwak JY, Bae YS.
    Biochem Biophys Res Commun; 2005 May 13; 330(3):989-98. PubMed ID: 15809093
    [Abstract] [Full Text] [Related]

  • 14. Cyclic AMP signaling as a mediator of vasculogenic mimicry in aggressive human melanoma cells in vitro.
    Lissitzky JC, Parriaux D, Ristorcelli E, Vérine A, Lombardo D, Verrando P.
    Cancer Res; 2009 Feb 01; 69(3):802-9. PubMed ID: 19176384
    [Abstract] [Full Text] [Related]

  • 15. VIP and PACAP receptor pharmacology: a comparison of intracellular signaling pathways.
    Dickson L, Aramori I, Sharkey J, Finlayson K.
    Ann N Y Acad Sci; 2006 Jul 01; 1070():239-42. PubMed ID: 16888173
    [Abstract] [Full Text] [Related]

  • 16. cAMP cascade (PKA, Epac, adenylyl cyclase, Gi, and phosphodiesterases) regulates myelin phagocytosis mediated by complement receptor-3 and scavenger receptor-AI/II in microglia and macrophages.
    Makranz C, Cohen G, Reichert F, Kodama T, Rotshenker S.
    Glia; 2006 Mar 01; 53(4):441-8. PubMed ID: 16345030
    [Abstract] [Full Text] [Related]

  • 17. VPAC1 (vasoactive intestinal peptide (VIP) receptor type 1) G protein-coupled receptor mediation of VIP enhancement of murine experimental colitis.
    Yadav M, Huang MC, Goetzl EJ.
    Cell Immunol; 2011 Mar 01; 267(2):124-32. PubMed ID: 21295288
    [Abstract] [Full Text] [Related]

  • 18. Utilization of two seven-transmembrane, G protein-coupled receptors, formyl peptide receptor-like 1 and formyl peptide receptor, by the synthetic hexapeptide WKYMVm for human phagocyte activation.
    Le Y, Gong W, Li B, Dunlop NM, Shen W, Su SB, Ye RD, Wang JM.
    J Immunol; 1999 Dec 15; 163(12):6777-84. PubMed ID: 10586077
    [Abstract] [Full Text] [Related]

  • 19. Mechanisms and modulation of pituitary adenylate cyclase-activating protein-induced calcium mobilization in human neutrophils.
    Harfi I, Sariban E.
    Ann N Y Acad Sci; 2006 Jul 15; 1070():322-9. PubMed ID: 16888186
    [Abstract] [Full Text] [Related]

  • 20. Serine 447 in the carboxyl tail of human VPAC1 receptor is crucial for agonist-induced desensitization but not internalization of the receptor.
    Marie JC, Rouyer-Fessard C, Couvineau A, Nicole P, Devaud H, El Benna J, Laburthe M.
    Mol Pharmacol; 2003 Dec 15; 64(6):1565-74. PubMed ID: 14645688
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.